CKD-393 formulation I
A98_04BE2022P
Phase 1 small_molecule completed
Quick answer
CKD-393 formulation I for Type II Diabetes is a Phase 1 program (small_molecule) at Hong Kong Baptist University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hong Kong Baptist University
- Indication
- Type II Diabetes
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed